l Introduction
Respiratory distress syndrome (RDS) is the main cause of death among premature newborn infants [21] . Despite recent improvements in treatment by neonatal intensive care and respiratory assistance, mortality from RDS remains high [20] . Inadequate pulmonary surfactant is thought to be a primary factor leading to the development of RDS [2] · LIGGINS [12] was the first to observe an accelerated lung maturity of fetal lambs treated in utero with glucocorticoids. LIGGINS and HOWIE [14] first reported the beneficial effect of the maternal administration of antepartum glucocorticoid on the incidence of RDS in premature infants. This has since been confirmed by others [3, 5, 8, 18] . However, attention must be drawn to the possibility of an adverse effect of corticosteroid treatment in cases with hypertensionedema-proteinuria syndromes. In this group a significantly higher fetal death rate was observed under betamethasone therapy [13] . Studies indicating a high incidence of RDS in neonatal hypothyroidism [25] suggest the possibility that thyroid hormones may play an important role on fetal lung maturation. Several animal studies have suggested an important influence of thyroid hormones on acceleration of lung maturation and enhancement of surfactant production [22, 27] . 
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Since maternal thyroid hormones cross the placenta in low concentration, the fetus depends primarily upon endogenous production. SACK et al. [23] showed that in sheep fetus, thyroxin injected into the amniotic sac was absorbed and distributed through the fetal body äs if it were injected directly into the fetus. MASHIAH et al. [17] reported good results in the 16 prematures treated by intraamniotic injection of 250 mg of levothyroxine. Triidothyronine (T 3 ) is similar to thyroxine (T 4 ) in its biological action but is more potent on a molar basis [11] . Approximately 20 per cent of T 4 is converted to T 3 [19] . In this study, we investigated the influence of intraamniotic T 3 administration upon -fetal plasma levels of T 3 , TSR, and upon the fetal outcome in patients with impending premature delivery and hypertensive disorders in pregnancy.
Patients and methods
Fifteen patients with severe hypertensive disease in pregnancy with threatened spontaneous or elective pre-term deliveries were investigated. The characteristics of the patient population is shown in Tab. L Amniocentesis and intraamniotic T 3 injection was performed following ultrasonic localization of the placenta in all cases. Following amniocentesis, 40 micrograms of T 3 (Triiodothyronine-Glaxo) were injected into the amniotic sac. All patients underwent continuous monitoring till labor and during delivery. Scalp pH values were evaluated in those patients with monitor evidence of fetal distress. Fetal arterial blood samples were collected in a heparinized syringe after delivery and cord clamping. Additional venous blood samples were collected 24,48 and 72 hours after delivery.
In a control group of eighi spontaneous pre-term deliveries of unknown cause without T 3 treatment, cord and venous blood samples from the newborns were collected at identical intervals. Gestational age in this control group was 33.6 ± 1.9 weeks. All patients were free of hypertensive disorders or diabetes mellitus. The modes of delivery were vaginal in six and cesarean section in two cases (Tab. I). Blood samples were centrifuged at 2000 r.p.m. for 10 minutes, the serum separäted and stored at -20 °C until analyzed. Triiodothyronine was analyzed by radioimmunoassay utilizing serulate kits, manufactüred by AMES-YISSUM, Jerusalem. The intra^assay coefficient of variance was found to be less than 6%. The cross reactivity of the T 3 anti-serum to thyroxine was found to be less than 0.19%. The TSR was analyzed by radioimmunoassay utilizing Phadebas kits, PHARMACIA PIAG-NOSTICS, Uppsala, Sweden. The test is highly specific, cross reactivity with LH being less than 0.1%, with FSH less than 0.01% and with hCG less than 0.002% by weight. Triiodothyronine values in the umbilical cord blood and concurrent venous blood samples in the treated and untreated groups are shown in Tab. III. No signiflcant differences were noted between the two groups. TSH values of cord blood in the treated group ranged between 2.0 and 8.2 μΐΐ/ml (4.6 ± 1.8 μΐΐ/ ml), while the control group TSH was between 3.0 and 11.2 μΐΐ/ml (5.1 ± 2.2 μϋ/ml), the differences being statistically non-significant In seven cases amniotic fluid T 3 levels were evaluated following intraamniotic triiodothyronine injection. The interval between administration of T 3 -and sampling ranged from 6 to 51 hours, and amniotic T 3 values ranged from 275 to more than 600 ng/dl. These values are excessively high. In one patient with a twin pregnancy and preeclamptic toxemia, repeat caesarean section was performed at 33 weeks because of fetal acidosis (pH = 7.21) appearing 1% hours after T 3 instillation into one of the amniotic sacs. No significant differences between the cord blood T 3 and TSH levels were registered. Twenty four hours after delivery, both twins showed a similar rise of serum T 3 and TSH levels ( Low APGAR scores (0-6) occurred in ten out of the 15 neonates (67%). In seven cases (43.8%), the newborns suffered from respiratory distress syndrome (RDS) and three of them died. Five out of the seven infants with RDS were born depressed (APGAR 1-6). The characteristics of the group with RDS is presented in Tab. IV. In the control group, no cases of RDS occurred.
Tab. III. Triiodothyronine levels (ng/dl) in cord blood and consequent blood samples in the two study groups. 
Discussion
While glucocorticoids are widely used for enhancing pulmonary maturation in threatened premature labors, their use in pregnancies complicated by a severe hypertensive state is probably contraindicated [13] , In these high risk pregnancies, with a high rate of planned and spontaneous premature labors, other agents which can effect formation of cyclic AMP, increasing the rate of surfactant production may be considered. Catecholamines, ACTH, glucagon, glucocorticoids, thyroxin and triiodothyronine augment the concentrations of AMP levels through adenyl cyclase activation. REDDING and DOUGLAS [22] reported an increased number and size of lamelar bodies and amount of surfactant recovered by alveolar washing in adult rats injected with L-thyroxine. Wu et al. [27] found that thyroxine injected into rabbit fetuses at 24 days of gestation resulted in accelerated maturation of surfactant System. Intraamniotic injection of thyroxine in an amount of 200 mcg, enhanced surfactant production äs manifested by a decrease in the level of fluorescence polarization (P value) of the amniotic fluid [15] . The same authors found a low incidence of RDS in a group of patients delivered between 29 and 34 weeks after intraamniotic injection of T 4 [16] .
In Üie present small series of very high risk pregnancies and premature deliveries, intraamniotic injection of T 3 in the amount of 40 mcg had no apparent beneficial effect upon the development of severe RDS. The frequency *of RDS was 46.6% (7 out of 15 cases), since it was a selected group with a high incidence of fetal depression and acidosis. The incidence of RDS in such cases is high in spite of mature L/S ratio [26] or following dexamethasone therapy [27] . Further, the injection-delivery interval was wide, ranging from 6 t o 72 hours. An animal study showed that an interval of 48 hours was needed to enhance lung maturation after T 4 treatment [27] . In five out of the seven cases with RDS, the injection-delivery interval was less than 48 hours. Moreover, the incidence of RDS is essentially a function of gestational age [7] . The mean gestational age of the seven infants with RDS was 30.4 weeks äs compared with 33.1 weeks (excluding the two infants born after 37 weeks) of those without RDS. Finally, fetal blqod analysis of T 3 and TSH levels following delivery showed no evidence of T 3 reaching the fetal compartment. FISHER et al. [10] have demonstrated a suppression of TSH in human neonates 12-24 hours after intraamniotic injection of T 4 . Those cases were not stressed pregnancies with depressed infants. Since amniotic fluid values of T 3 following injection in seven cases of our study were found to be very high (275-600 ng/100 ml) äs compared to normal levels of 5-30 ng/100 ml reported respectively by ETLING [9] and BURMAN et al. [6] , the possibility of malabsorption of amniotic fluid by fetuses in distress cannot be ruled out.
Summary
Intraamniotic thyroxine administration has been reported äs beneficial in cases of pregnancy hypertension for fetal pulmonary maturity enhancement. Triiodothyronine (T 3 ) similar to thyroxine (T/0 except for its increased potency per mole was administered intraamniotically to 15 hypertensive patients with preterm deliveries. The hypertensive disorder was severe preeclamptic toxemia (7 cases) superimposed preeclampsia upon chronic hypertension (6 patients) and underlying diabetes mellitus (2 patients). Premature labor was elective in 8 and spontaneous in 7 cases. The mean gestational age was 32.4 weeks. The administrationdelivery interval following 40 mg intraamniotic T 3 ranged from 6 to 72 hours. Eight untreated spontaneous preterm deliveries (gestational age 33.6 weeks) served äs a control group. Blood samples were collected from the umbilical cord and from the newborn at intervals of 24,48 and 72 hours following delivery. Triiodothyronine and TSH levels were investigated by radioimmunoassay methods. Cord blood T 3 levels were similar in the treated (70.2 ± 10.4 ng/dl) and the control groups (71.2 ± 9.7 ng/dl). There were no significant differences in T 3 concentration between the two groups 24,48 and 72 hours after delivery. TSH values of cord blood in the study group ranged between 2.0 and 8.2 MU/ml (mean 4.6 /ml) and in the control group between 3.0 and 11.2 /ml (mean 5.1 /ml). These differences are not statistically significant. In the seven cases where amniotic fluid T 3 were determined at delivery, levels were excessively high (275-600 ng/dl). Low APGAR scores were noted in 10 of the 15 neonates. Respiratory distress syndrome occurred in seven cases (43.8%) with three deaths. The present study of 15 very high-risk, hypertensive patients with preterm deliveries does not seem to reveal any positive effect of 40 mcg intraamniotic T 3 administration upon the incidence and severity of respiratory distress syndrome. Fetal blood analysis of T 3 and TSH levels following delivery showed no evidence of triiodothyronine reaching the fetal compartment in these highly stressed pregnancies. Les concentrations de T 3 au sang du cordon sont semblables dans le groupe traite (70,2 ± 10,4 ng/dl) et dans le groupe temoin (71,2 ± 9,7 ng/dl). On n'a pas trouve de difference significative dans les concentrations de T 3 dans les 2 groupes, 24,48 et 72 heures apres 1'accouchement. Dans le groupe traite les concentrations de TSH au sang du cordon sont comprises entre 2 et 8,2
/ml (moyenne: 4,6 /ml) et entre 3 et 11,2 /ml (moyenne: 5,1 / ml dans le groupe temoin. Ces differences ne sont pas statistiquement significatives, Dans les 7 cas oü a determine la concentratkm amniotique en T 3 , les taux ont ete trouves eleves de fa^on tres importante (275 -600 ng/dl), Un score d'APGAR bas a ete note chez 10 des 15 nouveau-nes. Un syndrome de detresse respiratoire est survenu dans 7 cas (43,8%) avQC 3 deces. Gette etudechez 15 patientes a tres haut risque, hypertendues, ayant accouche prematurement ne semble pas mettre en evidence une action positive de Padministration intra-amniotique de 40 mcg de T 3 sur Tincidence et la severite du syndröme de detresse respiratoire. Les dosages de T 3 et de TSH dans le sang du nouveau-ne ne mettent pas en evidence de passage de la Triiodothyronine dans le compartiment foetal au cours de ces grossesses ä haüts facteurs de stress.
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